UCB S.A.: Rhinitis, Allergic trials

The registry lists 20 Rhinitis, Allergic studies with UCB S.A. as lead sponsor. 0 are open to participants now and 7 have results posted.

Phase 1 1Phase 2 2Phase 3 7Phase 4 8No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic RhinitisCompletedNCT00653224Phase 4Results posted
• Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 6 Months to 11 MonthsCompletedNCT00628108Phase 3Results posted
• A Study Evaluating the Efficacy and Impact on Health-related Quality of Life of Levocetirizine in Adults With Seasonal Allergic RhinitisCompletedNCT00621959Phase 4Results posted
• Safety Study of Levocetirizine Dihydrochloride Oral Liquid Formulation in Children Aged 1 to Less Than 6 Years Suffering From Allergic Rhinitis or Chronic Urticaria of Unknown OriginCompletedNCT00619801Phase 3Results posted
• Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing Seasonal Allergic Rhinitis (SAR) Symptoms in Ragweed Sensitive SubjectsCompletedNCT00295022Phase 4Results posted
• A Study to Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of Seasonal Allergic Rhinitis (SAR) in Sensitive Subjects Exposed to Ragweed PollenCompletedNCT00291642Phase 2Results posted
• ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life)CompletedNCT00160680Phase 4Results posted
• A Phase 1 Study of Cizutamig in IgE Mediated DiseasesWithdrawnNCT07408869Phase 1
• Efficacy and Safety of Cetirizine Tablets Versus Ketotifen Dry Syrup in Children With Perennial Allergic RhinitisCompletedNCT00639587Phase 3
• Evaluation of Safety of Levocetirizine in Routine Clinical Practice-non- Interventional StudyCompletedNCT00598780
• Efficacy of Levocetirizine and Cetirizine in Reducing Symptoms of Seasonal Allergic Rhinitis in Ragweed Sensitive SubjectsCompletedNCT00544388Phase 3
• Efficacy and Safety of Levocetirizine and Fexofenadine in Reducing Symptoms of Seasonal Allergic RhinitisCompletedNCT00542607Phase 4
• To Evaluate the Efficacy and Safety of Levocetirizine Versus Loratadine for Treatment of Seasonal Allergic RhinitisCompletedNCT00525278Phase 3
• Efficacy and Safety of Levocetirizine Versus Loratadine for the Treatment of Perennial Allergic RhinitisCompletedNCT00524836Phase 3
• Evaluation of Efficacy and Safety of Levocetirizine to Subjects With Perennial Allergic Rhinitis to House Dust MitesCompletedNCT00521131Phase 4
• Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SARCompletedNCT00521040Not applicable
• Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed PollenCompletedNCT00315523Phase 3
• LEADER (LEvocetirizine And DEsloratadine in Allergic Rhinitis)CompletedNCT00160589Phase 4
• POPULAR (Preference Of Patient Using Levocetirizine in Allergic Rhinitis)CompletedNCT00160537Phase 4
• Open Study to Evaluate the Safety of Levocetirizine in Young Children (2 - 6 Years) Suffering From Allergic RhinitisCompletedNCT00152412Phase 2